Artificial Sweeteners and Risk of Type 2 Diabetes in the Prospective NutriNet-Santé Cohort - PubMed (original) (raw)
. 2023 Sep 1;46(9):1681-1690.
doi: 10.2337/dc23-0206.
Mélanie Deschasaux-Tanguy 1, Eloi Chazelas 1, Laury Sellem 1, Nathalie Druesne-Pecollo 1, Younes Esseddik 1, Fabien Szabo de Edelenyi 1, Cédric Agaësse 1, Alexandre De Sa 1, Rebecca Lutchia 1, Chantal Julia 1 2, Emmanuelle Kesse-Guyot 1, Benjamin Allès 1, Pilar Galan 1, Serge Hercberg 1 2, Inge Huybrechts 3, Emmanuel Cosson 1 4, Sopio Tatulashvili 4, Bernard Srour 1, Mathilde Touvier 1
Affiliations
- PMID: 37490630
- PMCID: PMC10465821
- DOI: 10.2337/dc23-0206
Artificial Sweeteners and Risk of Type 2 Diabetes in the Prospective NutriNet-Santé Cohort
Charlotte Debras et al. Diabetes Care. 2023.
Abstract
Objective: To study the relationships between artificial sweeteners, accounting for all dietary sources (total and by type of artificial sweetener) and risk of type 2 diabetes (T2D), in a large-scale prospective cohort.
Research design and methods: The analyses included 105,588 participants from the web-based NutriNet-Santé study (France, 2009-2022; mean age 42.5 ± 14.6 years, 79.2% women). Repeated 24-h dietary records, including brands and commercial names of industrial products, merged with qualitative and quantitative food additive composition data, enabled artificial sweetener intakes to be accurately assessed from all dietary sources. Associations between artificial sweeteners (total, aspartame, acesulfame potassium [K], and sucralose) and T2D were investigated using Cox proportional hazard models adjusted for potential confounders, including weight variation during follow-up.
Results: During a median follow-up of 9.1 years (946,650 person-years, 972 incident T2D), compared with nonconsumers, higher consumers of artificial sweeteners (i.e., above the sex-specific medians of 16.4 mg/day in men and 18.5 mg/day in women) had higher risks of developing T2D (hazard ratio [HR] 1.69; 95% CI 1.45-1.97; P-trend <0.001). Positive associations were also observed for individual artificial sweeteners: aspartame (HR 1.63 [95% CI 1.38-1.93], P-trend <0.001), acesulfame-K (HR 1.70 [1.42-2.04], P-trend <0.001), and sucralose (HR 1.34 [1.07-1.69], P-trend = 0.013).
Conclusions: Potential for reverse causality cannot be eliminated; however, many sensitivity analyses were computed to limit this and other potential biases. These findings of positive associations between artificial sweetener intakes and increased T2D risk strengthen the evidence that these additives may not be safe sugar alternatives. This study provides important insights in the context of on-going reevaluation of artificial sweeteners by health authorities worldwide.
© 2023 by the American Diabetes Association.
Conflict of interest statement
Duality of Interest. No potential conflicts of interest relevant to this article were reported.
Figures
Graphical abstract
Figure 1
Association between total artificial sweeteners, aspartame, acesulfame-K, and sucralose intakes and T2D risk, NutriNet-Santé cohort, France, 2009-2022 (N = 105,588). Median follow-up time was 9.13 years (946,650 person-years). Multivariable Cox proportional hazard models were adjusted for (main model) age (time scale), sex, BMI (continuous, kg/m2), mean percentage of weight change per year of follow-up (continuous), physical activity (categorical IPAQ variable: high, moderate, low, missing value), smoking status (categorical: never, former, current smokers), number of smoked cigarettes in pack-years (continuous), educational level (categorical: less than high school degree, <2 years after high school degree, ≥2 years after high school degree), family history of diabetes in first-degree relatives (categorical: yes, no), prevalence of cardiovascular disease (categorical: yes, no), prevalence of hypertension (categorical: yes, no), prevalence of dyslipidemia (categorical: yes, no), number of 24-h dietary records (continuous), energy intake without alcohol (continuous variable: kcal/day), daily intakes (continuous, g/day) of alcohol, sodium, saturated fatty acids, fiber, sugar, fruit and vegetables, red and processed meat, and dairy products. In addition, all models were mutually adjusted for artificial sweetener intake other than the one studied. Sex specific cutoffs among consumers were 16.4 mg/day in men and 18.5 mg/day in women for total artificial sweeteners, 13.3 mg/day in men and 15.0 mg/day in women for aspartame, 5.05 mg/day in men and 5.40 mg/day in women for acesulfame-K, and 3.44 mg/day in men and 3.30 mg/day in women for sucralose.
Figure 2
Dose-response associations between artificial sweetener intakes and T2D, NutriNet-Santé, France, 2009-2022 (N =105,588). Median follow-up time was 9.13 years (946,650 person-years). Multivariable Cox proportional hazard models were adjusted for (main model) age (time scale), sex, BMI (continuous, kg/m2), mean percentage of weight-change per year of follow-up (continuous), physical activity (categorical IPAQ variable: high, moderate, low, missing value), smoking status (categorical: never, former, current smokers), number of smoked cigarettes in pack-years (continuous), educational level (categorical: less than high school degree, <2 years after high school degree, ≥2 years after high school degree), family history of diabetes in first-degree relatives (categorical: yes, no), prevalence of cardiovascular disease (categorical: yes, no), prevalence of hypertension (categorical: yes, no), prevalence of dyslipidemia (categorical: yes, no), number of 24h dietary records (continuous), energy intake without alcohol (continuous variable: kcal/day), daily intakes (continuous, g/day) of alcohol, sodium, saturated fatty acids, fiber, sugar, fruits and vegetables, red and processed meat, and dairy products. In addition, all models were mutually adjusted for artificial sweetener intake other than the one studied. Restricted cubic splines functions with the SAS macro were developed by Desquilbet and Mariotti (1).
Comment in
- Süßstoffe begünstigen Diabetes-Entwicklung.
Wirth A. Wirth A. MMW Fortschr Med. 2024 Feb;166(3):28. doi: 10.1007/s15006-024-3649-1. MMW Fortschr Med. 2024. PMID: 38389002 Review. German. No abstract available.
Similar articles
- Artificial sweeteners and cancer risk: Results from the NutriNet-Santé population-based cohort study.
Debras C, Chazelas E, Srour B, Druesne-Pecollo N, Esseddik Y, Szabo de Edelenyi F, Agaësse C, De Sa A, Lutchia R, Gigandet S, Huybrechts I, Julia C, Kesse-Guyot E, Allès B, Andreeva VA, Galan P, Hercberg S, Deschasaux-Tanguy M, Touvier M. Debras C, et al. PLoS Med. 2022 Mar 24;19(3):e1003950. doi: 10.1371/journal.pmed.1003950. eCollection 2022 Mar. PLoS Med. 2022. PMID: 35324894 Free PMC article. - Artificial sweeteners and risk of cardiovascular diseases: results from the prospective NutriNet-Santé cohort.
Debras C, Chazelas E, Sellem L, Porcher R, Druesne-Pecollo N, Esseddik Y, de Edelenyi FS, Agaësse C, De Sa A, Lutchia R, Fezeu LK, Julia C, Kesse-Guyot E, Allès B, Galan P, Hercberg S, Deschasaux-Tanguy M, Huybrechts I, Srour B, Touvier M. Debras C, et al. BMJ. 2022 Sep 7;378:e071204. doi: 10.1136/bmj-2022-071204. BMJ. 2022. PMID: 36638072 Free PMC article. - Food additive mixtures and type 2 diabetes incidence: Results from the NutriNet-Santé prospective cohort.
Payen de la Garanderie M, Hasenbohler A, Dechamp N, Javaux G, Szabo de Edelenyi F, Agaësse C, De Sa A, Bourhis L, Porcher R, Pierre F, Coumoul X, Kesse-Guyot E, Allès B, Fezeu LK, Cosson E, Tatulashvili S, Huybrechts I, Hercberg S, Deschasaux-Tanguy M, Chassaing B, Rytter H, Srour B, Touvier M. Payen de la Garanderie M, et al. PLoS Med. 2025 Apr 8;22(4):e1004570. doi: 10.1371/journal.pmed.1004570. eCollection 2025 Apr. PLoS Med. 2025. PMID: 40198579 Free PMC article. - Artificial sweeteners: safe or unsafe?
Qurrat-ul-Ain, Khan SA. Qurrat-ul-Ain, et al. J Pak Med Assoc. 2015 Feb;65(2):225-7. J Pak Med Assoc. 2015. PMID: 25842566 Review.
Cited by
- Artificial sweeteners and risk of incident cardiovascular disease and mortality: evidence from UK Biobank.
Sun T, Yang J, Lei F, Huang X, Liu W, Zhang X, Lin L, Sun L, Xie X, Zhang XJ, Cai J, She ZG, Xu C, Li H. Sun T, et al. Cardiovasc Diabetol. 2024 Jul 4;23(1):233. doi: 10.1186/s12933-024-02333-9. Cardiovasc Diabetol. 2024. PMID: 38965574 Free PMC article. - Chronic Use of Artificial Sweeteners: Pros and Cons.
Kossiva L, Kakleas K, Christodouli F, Soldatou A, Karanasios S, Karavanaki K. Kossiva L, et al. Nutrients. 2024 Sep 19;16(18):3162. doi: 10.3390/nu16183162. Nutrients. 2024. PMID: 39339762 Free PMC article. Review. - Ultra-processed food consumption and risk of diabetes: results from a population-based prospective cohort.
Du S, Sullivan VK, Fang M, Appel LJ, Selvin E, Rebholz CM. Du S, et al. Diabetologia. 2024 Oct;67(10):2225-2235. doi: 10.1007/s00125-024-06221-5. Epub 2024 Jul 13. Diabetologia. 2024. PMID: 39001935 Free PMC article. - The impact of dietary interventions on cardiometabolic health.
Gjermeni E, Fiebiger R, Bundalian L, Garten A, Schöneberg T, Le Duc D, Blüher M. Gjermeni E, et al. Cardiovasc Diabetol. 2025 May 31;24(1):234. doi: 10.1186/s12933-025-02766-w. Cardiovasc Diabetol. 2025. PMID: 40450314 Free PMC article. Review. - Overnutrition in the Elderly Population: Socio-Demographic and Behavioral Risk Factors in Hungary.
Ulambayar B, Ghanem AS, Nagy AC. Ulambayar B, et al. Nutrients. 2025 Jun 8;17(12):1954. doi: 10.3390/nu17121954. Nutrients. 2025. PMID: 40573065 Free PMC article.
References
- Mooradian AD, Smith M, Tokuda M. The role of artificial and natural sweeteners in reducing the consumption of table sugar: a narrative review. Clin Nutr ESPEN 2017;18:1–8 - PubMed
- U.S. Food and Drug Administration . Aspartame and Other Sweeteners in Food. 2018. Accessed 2 March 2018. Available from https://www.fda.gov/food/food-additives-petitions/additional-information...
- Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail. Ciqual Table de composition nutritionnelle des aliments. Accessed 8 February 2021. Available from https://ciqual.anses.fr/
- Rios-Leyvraz M, Montez J. Health effects of the use of non-sugar sweeteners: a systematic review and meta-analysis. Geneva: World Health Organization, 2022. Accessed 27 April 2022. Available from https://www.who.int/publications/i/item/9789240046429
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical